Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about INCY

Recent news which mentions INCY

< Previous 1 2 3 4 5 6 7 8 9 Next >
Exit Now! 3 Biotech Stocks to Sell in February 2024
Tickers INCY MOR NVS SAVA
Tags Market News NVAS MOR
From InvestorPlace
The Analyst Verdict: Incyte In The Eyes Of 8 Experts
Tickers INCY
Tags Analyst Ratings Benzinga BZI/AAR
From Benzinga
Earnings Scheduled For February 13, 2024
Tickers ABNB ADC AIG AKAM
Tags AKAM BZI/UE KRG
From Benzinga
Novartis Agrees To Acquire German Blood Cancer-Drug Developer MorphoSys For €2.7B
Tickers INCY MOR NEWS NVS
Tags Briefs INCY News
From Benzinga
Why Is MorphoSys (MOR) Stock Up 50% Today?
Tickers INCY MOR NVS
Tags MOR Market News NASDAQ:MOR,NYSE:NVS,NASDAQ:INCY
From InvestorPlace
MorphoSys Stock Soars After Report Says Novartis To Acquire Cancer-Drug Developer
Tickers INCY MOR NEWS NVS
Tags Biotech INCY News
From Benzinga
3 Pharma Stocks Could Be the Pills Your Portfolio Needs
Tickers EXEL INCY PFE SGEN
Tags NYSE:PFE,NASDAQ:SGEN,NASDAQ:INCY,NASDAQ:EXEL INCY SGEN
From InvestorPlace
Analyst Highlights Aclaris Therapeutics' Encouraging Efficacy For Eczema Candidate, But Cautions On Data Variations
Tickers ACRS INCY NEWS ROIV
Tags Market News Benzinga Expert Ideas
From Benzinga
AI Meets Biotech: 3 Top Stocks Transforming Medical Science
Tickers ABCL BAYRY DNA GOOG
Tags RXRX ABCL Expert Stock Picks
From InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy in December
Tickers INCY KNSA NBIX RHHBY
Tags NASDAQ:KNSA,OTCMKTS:RHHBY,NASDAQ:NBIX,NASDAQ:INCY Stocks to Buy KNSA
From InvestorPlace
Expert Ratings for Incyte
Tickers INCY
Tags Analyst Ratings Benzinga BZI/AAR
From Benzinga
What's Up With Incyte Stock Lately?
Tickers INCY
Tags why it's moving Benzinga INCY
From Benzinga
S&P 500's Hidden Gems: 27 Stocks With 30%+ Upside Potential According To Wall Street Analysts Targets
Tickers ALB ALGN ALK APA
Tags MRO NVDA ALK
From Benzinga
Goldman Sachs Downgrades Incyte Amid Concerns Over Jakafi Studies, Competitiveness
Tickers INCY
Tags Analyst Ratings Health Care Briefs
From Benzinga
The Latest Analyst Ratings for Incyte
Tickers INCY
Tags Analyst Ratings Benzinga BZI/AAR
From Benzinga
3 Biotech Stocks That Are Poised to Have Breakthroughs in 2024
Tickers CRSP INCY SWAV
Tags NASDAQ:SWAV,NASDAQ:CRSP,NASDAQ:INCY SWAV Market News
From InvestorPlace
7 Underappreciated Biotech Stocks to Pick Up on the Cheap
Tickers BNTX CORT GMAB HALO
Tags CORT Market News PFE
From InvestorPlace
Goldman Sachs Maintains Buy Rating for Incyte: Here's What You Need To Know
Tickers INCY
Tags Benzinga Analyst Ratings INCY
From Benzinga
Earnings Outlook For Incyte
Tickers INCY
Tags Benzinga INCY Earnings
From Benzinga
Quant Ratings Updated on 73 Stocks
Tickers ABT AWK CL CNI
Tags GD ABT CNI
From InvestorPlace
Expert Ratings for Incyte
Tickers INCY
Tags Benzinga BZI/AAR Analyst Ratings
From Benzinga
3 Biotech Stocks That Should Be on Every Investor’s Radar This Fall
Tickers EXEL INCY JAZZ
Tags NASDAQ:JAZZ,NASDAQ:INCY,NASDAQ:EXEL EXEL Market News
From InvestorPlace
Anemia Advantage For GSK's Blood Cancer Therapy Could Influence Market Share Despite Incyte's Jakafi Comparison
Tickers BMY GSK INCY
Tags Health Care GSK Analyst Ratings
From Benzinga
Analyst Ratings for Incyte
Tickers INCY
Tags Analyst Ratings BZI/AAR Benzinga
From Benzinga
Incyte's Jakafi Patent Expiry In 2028 Poses Challenge, Analyst Says New Treatments To Battle For Market Share
Tickers INCY
Tags Expert Ideas Analyst Color Guidance
From Benzinga
Incyte's Earnings Outlook
Tickers INCY
Tags BZI/EP Earnings Market News
From Benzinga
Cathie Wood's Ark Invest Buys Spotify, Iridium Shares — Trims Tesla, Coinbase Holdings
Tickers ACCD AIR ARKQ ARKW
Tags ARK Investment Management Tesla Cathie Wood
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2023
Tickers ABBV AGLE AI AVNS
Tags Initiation PROK Benzinga
From Benzinga
Syndax-Incyte Partnered Chronic Graft-Versus-Host Disease Achieves Primary Endpoint In Pivotal Trial, FDA Submission Planned By 2023 End
Tickers INCY SNDX
Tags Market News Health Care Benzinga
From Benzinga
'I Don't Want You To Touch That': Cramer Rejects Stock Down 32% Over Past Month, Prefers Tesla
Tickers ARE ASTS CNC FRT
Tags ARE Benzinga Market News
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.